Century Therapeutics (IPSC) Stock Chart & Stock Price History $0.50 0.00 (-0.76%) As of 11:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Century Therapeutics Stock Price Performance The Century Therapeutics (IPSC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 69.19%, with a year-to-date return of -50.89%. In the past month, the stock has increased 3.33%, reflecting recent market activity. As of the latest close, Century Therapeutics traded at $0.50 with a market cap of $43.18 million and volume of 381,861 shares. Receive IPSC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.57%1 Month Performance+3.33%3 Month Performance-10.63%Year-To-Date Performance-50.89%1 Year Performance-69.19% IPSC Stock Chart for Thursday, October, 2, 2025 IPSC Chart by TradingView Century Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/01/2025$0.50$0.50+0.36%$0.51$0.50381,861 shs$43.18 million09/30/2025$0.50$0.50-0.32%$0.50$0.49233,202 shs$43.02 million09/29/2025$0.51$0.50-1.87%$0.51$0.49357,291 shs$43.16 million09/26/2025$0.49$0.51+4.39%$0.52$0.48531,656 shs$43.98 million09/25/2025$0.48$0.49+0.66%$0.50$0.48420,195 shs$42.13 million09/24/2025$0.49$0.48-0.19%$0.50$0.48362,727 shs$41.86 million09/23/2025$0.48$0.49+1.13%$0.50$0.48432,092 shs$41.93 million09/22/2025$0.48$0.48+0.59%$0.49$0.48319,656 shs$41.47 million09/19/2025$0.51$0.48-5.88%$0.51$0.48690,075 shs$41.23 million09/18/2025$0.49$0.51+3.07%$0.51$0.49271,278 shs$43.80 million Get the Latest News and Ratings for IPSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/17/2025$0.49$0.49+0.43%$0.52$0.49149,750 shs$42.50 million09/16/2025$0.50$0.49-1.49%$0.51$0.48266,860 shs$42.31 million09/15/2025$0.50$0.50-0.72%$0.52$0.49273,398 shs$42.95 million09/12/2025$0.52$0.50-3.38%$0.51$0.49309,742 shs$43.26 million09/11/2025$0.51$0.52+2.09%$0.52$0.49345,007 shs$44.78 million09/10/2025$0.50$0.51+0.95%$0.52$0.49539,167 shs$43.86 million09/09/2025$0.51$0.50-1.45%$0.52$0.50391,111 shs$43.45 million09/08/2025$0.50$0.51+1.11%$0.52$0.50661,481 shs$44.08 million09/05/2025$0.48$0.50+5.41%$0.51$0.49548,009 shs$43.60 million09/04/2025$0.47$0.48+2.26%$0.48$0.46768,498 shs$41.36 million09/03/2025$0.48$0.47-2.46%$0.50$0.47395,824 shs$40.45 million09/02/2025$0.49$0.48-2.04%$0.50$0.47942,879 shs$41.47 million09/01/2025$0.49$0.49$0.52$0.49502,850 shs$42.33 million Related Companies VTYX Stock Price Chart ENTA Stock Price Chart MIST Stock Price Chart PLX Stock Price Chart NLTX Stock Price Chart NVCT Stock Price Chart CRBU Stock Price Chart GNLX Stock Price Chart CLYM Stock Price Chart BTMD Stock Price Chart Receive IPSC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPSC) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierThis innovative drone developer has been selected to supply its Flex FPV Modular Drones to the U.S. Army. T...The Tomorrow Investor | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Century Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
